Profil
Samuel Agus is currently the Chief Medical Officer at Biophytis, Inc. He previously held the same position at Biophytis SA from 2018 to 2021 and at Hansa Biopharma AB from 2017 to 2018.
Agus holds a doctorate degree from Tel-Aviv University and The Hebrew University of Jerusalem.
Postes actifs de Samuel Agus
| Sociétés | Poste | Début |
|---|---|---|
Biophytis, Inc.
Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes | Directeur Technique/Scientifique/R&D | 01/07/2018 |
Anciens postes connus de Samuel Agus
| Sociétés | Poste | Fin |
|---|---|---|
| BIOPHYTIS S.A. | Directeur Technique/Scientifique/R&D | 07/07/2021 |
| HANSA BIOPHARMA AB | Directeur Technique/Scientifique/R&D | 01/06/2018 |
Formation de Samuel Agus
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Biophytis SA
Biophytis SA Pharmaceuticals: OtherHealth Technology Develops and markets dietary supplements and ingredients for functional food based on tropical plants | Health Technology |
Biophytis, Inc.
Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes | Health Technology |
















